相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Fibroblast Growth Factor 19-Mediated Up-regulation of SYR-Related High-Mobility Group Box 18 Promotes Hepatocellular Carcinoma Metastasis by Transactivating Fibroblast Growth Factor Receptor 4 and Fms-Related Tyrosine Kinase 4
Jie Chen et al.
HEPATOLOGY (2020)
Six1 proteins with human branchio-oto-renal mutations differentially affect cranial gene expression and otic development
Ankita M. Shah et al.
DISEASE MODELS & MECHANISMS (2020)
Cooperation Between MYC and β-Catenin in Liver Tumorigenesis Requires Yap/Taz
Andrea Bisso et al.
HEPATOLOGY (2020)
Molecular therapies for HCC: Looking outside the box
Sandrine Faivre et al.
JOURNAL OF HEPATOLOGY (2020)
Tumour evolution in hepatocellular carcinoma
Amanda J. Craig et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)
The EGFR-ZNF263 signaling axis silences SIX3 in glioblastoma epigenetically
Zhibin Yu et al.
ONCOGENE (2020)
The Function of the HGF/c-Met Axis in Hepatocellular Carcinoma
Haiyu Wang et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
MET Inhibitors Promote Liver Tumor Evasion of the Immune Response by Stabilizing PDL1
Hui Li et al.
GASTROENTEROLOGY (2019)
Crucial and Overlapping Roles of Six1 and Six2 in Craniofacial Development
Z. Liu et al.
JOURNAL OF DENTAL RESEARCH (2019)
SIX4 acts as a master regulator of oncogenes that promotes tumorigenesis in non-small-cell lung cancer cells
Xiaoping Tang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
A global view of hepatocellular carcinoma: trends, risk, prevention and management
Ju Dong Yang et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
Verteporfin-induced lysosomal compartment dysregulation potentiates the effect of sorafenib in hepatocellular carcinoma
Jacopo Gavini et al.
CELL DEATH & DISEASE (2019)
SIX2 Mediates Late-Stage Metastasis via Direct Regulation of SOX2 and Induction of a Cancer Stem Cell Program
Michael U. J. Oliphant et al.
CANCER RESEARCH (2019)
EGFR and c-MET Cooperate to Enhance Resistance to PARP Inhibitors in Hepatocellular Carcinoma
Qiongzhu Dong et al.
CANCER RESEARCH (2019)
Role of the transcriptional coactivators YAP/TAZ in liver cancer
Shihao Zhang et al.
CURRENT OPINION IN CELL BIOLOGY (2019)
Transcriptional Regulation of the Warburg Effect in Cancer by SIX1
Ling Li et al.
CANCER CELL (2018)
High mobility group protein B1 controls liver cancer initiation through yes-associated protein -dependent aerobic glycolysis
Ruochan Chen et al.
HEPATOLOGY (2018)
Recent developments of c-Met as a therapeutic target in hepatocellular carcinoma
Mohamed Bouattour et al.
HEPATOLOGY (2018)
Function of the c-Met receptor tyrosine kinase in carcinogenesis and associated therapeutic opportunities
Yazhuo Zhang et al.
MOLECULAR CANCER (2018)
The Homeotic Protein SIX3 Suppresses Carcinogenesis and Metastasis through Recruiting the LSD1/NuRD(MTA3) Complex
Yu Zheng et al.
THERANOSTICS (2018)
Yap promotes hepatocellular carcinoma metastasis and mobilization via governing cofilin/F-actin/lamellipodium axis by regulation of JNK/Bnip3/SERCA/CaMKII pathways
Chen Shi et al.
REDOX BIOLOGY (2018)
Yes-associated protein (YAP) binds to HIF-1α and sustains HIF-1α protein stability to promote hepatocellular carcinoma cell glycolysis under hypoxic stress
Xiaodong Zhang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Updates on the hepatocyte growth factor/c-Met axis in hepatocellular carcinoma and its therapeutic implications
Javier A. Garcia-Vilas et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
HGF/MET and the Immune System: Relevance for Cancer Immunotherapy
Federica Papaccio et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Known and novel roles of the MET oncogene in cancer: a coherent approach to targeted therapy
Paolo M. Comoglio et al.
NATURE REVIEWS CANCER (2018)
Hippo Signaling in the Liver Regulates Organ Size, Cell Fate, and Carcinogenesis
Sachin H. Patel et al.
GASTROENTEROLOGY (2017)
Phase I Results from a Study of Crizotinib in Combination with Erlotinib in Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer
Sai-Hong Ignatius Ou et al.
JOURNAL OF THORACIC ONCOLOGY (2017)
SIX4 promotes metastasis via activation of the PI3K-AKT pathway in colorectal cancer
Guodong Li et al.
PEERJ (2017)
The Therapeutic Targeting of HGF/c-Met Signaling in Hepatocellular Carcinoma: Alternative Approaches
Chi-Tan Hu et al.
CANCERS (2017)
HGF/Met Signaling in Cancer Invasion: The Impact on Cytoskeleton Remodeling
Chuan Xiang et al.
CANCERS (2017)
Molecular Features of the YAP Inhibitor Verteporfin: Synthesis of Hexasubstituted Dipyrrins as Potential Inhibitors of YAP/TAZ, the Downstream Effectors of the Hippo Pathway
Floriane Gibault et al.
CHEMMEDCHEM (2017)
Cancer-Associated Fibroblasts Regulate Tumor-Initiating Cell Plasticity in Hepatocellular Carcinoma through c-Met/FRA1/HEY1 Signaling
Eunice Yuen Ting Lau et al.
CELL REPORTS (2016)
MicroRNA-26a Suppresses Angiogenesis in Human Hepatocellular Carcinoma by Targeting Hepatocyte Growth Factor-cMet Pathway
Xin Yang et al.
HEPATOLOGY (2014)
Met as a therapeutic target in HCC: Facts and hopes
Silvia Giordano et al.
JOURNAL OF HEPATOLOGY (2014)
The c-Met Inhibitor MSC2156119J Effectively Inhibits Tumor Growth in Liver Cancer Models
Friedhelm Bladt et al.
CANCERS (2014)
Amplification of the MET Receptor Drives Resistance to Anti-EGFR Therapies in Colorectal Cancer
Alberto Bardelli et al.
CANCER DISCOVERY (2013)
SIX1 induces lymphangiogenesis and metastasis via upregulation of VEGF-C in mouse models of breast cancer
Chu-An Wang et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
SIX1 promotes epithelial-mesenchymal transition in colorectal cancer through ZEB1 activation
H. Ono et al.
ONCOGENE (2012)
Targeting MET in cancer: rationale and progress
Ermanno Gherardi et al.
NATURE REVIEWS CANCER (2012)
A Novel Kinase Inhibitor, INCB28060, Blocks c-MET-Dependent Signaling, Neoplastic Activities, and Cross-Talk with EGFR and HER-3
Xiangdong Liu et al.
CLINICAL CANCER RESEARCH (2011)
A Perspective on Cancer Cell Metastasis
Christine L. Chaffer et al.
SCIENCE (2011)
Yes-Associated Protein Is an Independent Prognostic Marker in Hepatocellular Carcinoma
Michelle Z. Xu et al.
CANCER (2009)
Six1 expands the mouse mammary epithelial stem/progenitor cell pool and induces mammary tumors that undergo epithelial-mesenchymal transition
Erica L. McCoy et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Prognostic Impact of Surgical Complications and Preoperative Serum Hepatocyte Growth Factor in Hepatocellular Carcinoma Patients After Initial Hepatectomy
Toru Mizuguchi et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2009)
Elucidation of a universal size-control mechanism in Drosophila and mammals
Jixin Dong et al.
CELL (2007)
The Six1 homeoprotein stimulates tumorigenesis by reactivation of cyclin A1
RD Coletta et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Expression profiling identifies the cytoskeletal organizer ezrin and the developmental homeoprotein Six-1 as key metastatic regulators
YL Yu et al.
NATURE MEDICINE (2004)
Association between serum hepatocyte growth factor and survival in untreated hepatocellular carcinoma
P Vejchapipat et al.
JOURNAL OF GASTROENTEROLOGY (2004)
Dissemination and growth of cancer cells in metastatic sites
AF Chambers et al.
NATURE REVIEWS CANCER (2002)
分享论文
